These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8389655)

  • 41. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.
    Steinert HC; Hauser M; Allemann F; Engel H; Berthold T; von Schulthess GK; Weder W
    Radiology; 1997 Feb; 202(2):441-6. PubMed ID: 9015071
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Uptake of 2-deoxy, 2-(18F) fluoro-D-glucose in bladder cancer: animal localization and initial patient positron emission tomography.
    Harney JV; Wahl RL; Liebert M; Kuhl DE; Hutchins GD; Wedemeyer G; Grossman HB
    J Urol; 1991 Feb; 145(2):279-83. PubMed ID: 1988718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Positron emission tomography. Introduction of a new procedure in diagnosis of urologic tumors and initial clinical results].
    Bachor R; Kocher F; Gropengiesser F; Reske SN; Hautmann RE
    Urologe A; 1995 Mar; 34(2):138-42. PubMed ID: 7754585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma.
    Gritters LS; Francis IR; Zasadny KR; Wahl RL
    J Nucl Med; 1993 Sep; 34(9):1420-7. PubMed ID: 8355058
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
    Swinnen G; Maes A; Pottel H; Vanneste A; Billiet I; Lesage K; Werbrouck P
    Eur Urol; 2010 Apr; 57(4):641-7. PubMed ID: 19477579
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Positron emission tomography scanning in gynecologic and breast cancers.
    Zimny M; Siggelkow W
    Curr Opin Obstet Gynecol; 2003 Feb; 15(1):69-75. PubMed ID: 12544505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy.
    Mortimer JE; Dehdashti F; Siegel BA; Katzenellenbogen JA; Fracasso P; Welch MJ
    Clin Cancer Res; 1996 Jun; 2(6):933-9. PubMed ID: 9816253
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays.
    Dehdashti F; Mortimer JE; Siegel BA; Griffeth LK; Bonasera TJ; Fusselman MJ; Detert DD; Cutler PD; Katzenellenbogen JA; Welch MJ
    J Nucl Med; 1995 Oct; 36(10):1766-74. PubMed ID: 7562040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lung tumor metastasis to breast detected by fluorine-18-fluorodeoxyglucose PET.
    Hunter GJ; Choi NC; McLoud TC; Fischman AJ
    J Nucl Med; 1993 Sep; 34(9):1571-3. PubMed ID: 8394885
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Positron emission tomography: 2-deoxy-2-[18F]-fluoro-D-glucose uptake in locally advanced breast cancers.
    Bruce DM; Evans NT; Heys SD; Needham G; BenYounes H; Mikecz P; Smith FW; Sharp F; Eremin O
    Eur J Surg Oncol; 1995 Jun; 21(3):280-3. PubMed ID: 7781797
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy.
    Smith IC; Welch AE; Hutcheon AW; Miller ID; Payne S; Chilcott F; Waikar S; Whitaker T; Ah-See AK; Eremin O; Heys SD; Gilbert FJ; Sharp PF
    J Clin Oncol; 2000 Apr; 18(8):1676-88. PubMed ID: 10764428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Diagnosis of breast carcinoma and locoregional lymph nodes with positron emission tomography].
    Avril N; Dose J; Ziegler S; Jänicke F; Schwaiger M
    Radiologe; 1997 Sep; 37(9):741-8. PubMed ID: 9424620
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mediastinal staging of non-small-cell lung cancer with positron emission tomography.
    Chin R; Ward R; Keyes JW; Choplin RH; Reed JC; Wallenhaupt S; Hudspeth AS; Haponik EF
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2090-6. PubMed ID: 8520780
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
    Duhaylongsod FG; Lowe VJ; Patz EF; Vaughn AL; Coleman RE; Wolfe WG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):130-9; discussion 139-40. PubMed ID: 7609536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas.
    Laubenbacher C; Saumweber D; Wagner-Manslau C; Kau RJ; Herz M; Avril N; Ziegler S; Kruschke C; Arnold W; Schwaiger M
    J Nucl Med; 1995 Oct; 36(10):1747-57. PubMed ID: 7562038
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose.
    Wahl RL; Cody RL; Hutchins GD; Mudgett EE
    Radiology; 1991 Jun; 179(3):765-70. PubMed ID: 2027989
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET.
    Reinhardt MJ; Ehritt-Braun C; Vogelgesang D; Ihling C; Högerle S; Mix M; Moser E; Krause TM
    Radiology; 2001 Mar; 218(3):776-82. PubMed ID: 11230656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography.
    Flanagan FL; Dehdashti F; Siegel BA; Trask DD; Sundaresan SR; Patterson GA; Cooper JD
    AJR Am J Roentgenol; 1997 Feb; 168(2):417-24. PubMed ID: 9016218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dual time point FDG-PET/CT imaging... Potential tool for diagnosis of breast cancer.
    Zytoon AA; Murakami K; El-Kholy MR; El-Shorbagy E
    Clin Radiol; 2008 Nov; 63(11):1213-27. PubMed ID: 18929039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.